Neurofibromatosis type 1: vizsgálatok itt: Egyesült Államok
27 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleCyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
- Where
- Bethesda
- Életkor
- 12 év and over
- People
- 55
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04750928 - 3. fázisTaking peopleA Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
- Where
- Akron, Albany, Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boise, Boston, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Dallas, Danville, Dayton, Des Moines, Detroit, Durham, El Paso, Fargo, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Greenville, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, Knoxville, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madison, Memphis, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Morgantown, Morristown, Nashville, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Roanoke, Rochester, Royal Oak, Salt Lake City, San Antonio, San Diego, San Francisco, Scarborough, Seattle, Spokane, Springfield, St Louis, St. Petersburg, Syracuse, Tacoma, Tampa, Valhalla, Washington D.C., Wilmington, Winston-Salem
- Életkor
- 2 év to 21 év
- People
- 170 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04166409 - 1. fázisTaking peoplePhase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- Where
- Bethesda
- Életkor
- 3 év to 35 év
- People
- 54
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02390752 - No phaseTaking peopleSurveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
- Where
- Bethesda
- Életkor
- 3 év to 120 év
- People
- 225
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06222203 - No phaseTaking peopleDevelopment and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
- Where
- Baltimore, Bethesda, Chicago, Cincinnati, Philadelphia, Washington D.C.
- Életkor
- 5 év and over
- People
- 476
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02544022 - 1. fázisTaking peoplePAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
- Where
- Birmingham
- Életkor
- 18 év and over
- People
- 56 worldwide
- Run by
- Pasithea Therapeutics Corp.
See details and how to joinNCT06961565 - No phaseTaking peopleThe NF Registry Sponsored by the Children's Tumor Foundation
- Where
- New York
- People
- 20 000
- Run by
- The Children's Tumor Foundation
See details and how to joinNCT01885767 - No phaseTaking peopleAcceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
- Where
- Bethesda
- Életkor
- 18 év and over
- People
- 70
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05361811 - No phaseTaking peopleA Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
- Where
- Bethesda, Washington D.C.
- Életkor
- 1 év to 120 év
- People
- 70
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06507748 - No phaseTaking peopleDevelopment of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study
- Where
- Bethesda
- Életkor
- 5 év to 120 év
- People
- 110
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06880991 - 2. fázisNot yet taking people in Egyesült ÁllamokEfficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma
- Where
- Birmingham
- Életkor
- 12 év to 89 év
- People
- 55
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07521657 - 1. fázisTaking peopleStudy of Cabozantinib With Selumetinib for Plexiform Neurofibromas
- Where
- Birmingham, Boston, Cincinnati, Dallas, Indianapolis, Los Angeles, Philadelphia, Washington D.C.
- Életkor
- 16 év and over
- People
- 30
- Run by
- Girish Dhall, MD
See details and how to joinNCT06502171 - No phaseCsak meghívásosDeveloping Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1
- Where
- Chicago
- People
- 200
- Run by
- Ann & Robert H Lurie Children's Hospital of Chicago
See details and how to joinNCT05238909 - 1/2. fázisTaking peopleA Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Where
- Ann Arbor, Atlanta, Baltimore, Charlotte, Chicago, Cincinnati, Dallas, Denver, Indianapolis, Kansas City, Los Angeles, Memphis, Miami, New York, Philadelphia, Phoenix, Portland, Salt Lake City, San Francisco, Seattle, Washington D.C.
- Életkor
- 1 hónap to 21 év
- People
- 58
- Run by
- Therapeutic Advances in Childhood Leukemia Consortium
See details and how to joinNCT05849662 - No phaseCsak meghívásosNeurofibromatosis Type 1 Tumor Early Detection Study
- Where
- Boston
- Életkor
- 18 év and over
- People
- 1000
- Run by
- David Miller
See details and how to joinNCT06515860 - 2. fázisTaking peopleTrial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
- Where
- Birmingham
- Életkor
- 18 év to 99 év
- People
- 41
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT05253131 - 2. fázisTaking peopleA Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
- Where
- Aurora, Baltimore, Birmingham, Chicago, Cincinnati, Dallas, Indianapolis, Los Angeles, New York, Palo Alto, Philadelphia, St Louis, Washington D.C.
- Életkor
- 12 év and over
- People
- 25
- Run by
- Healx Limited
See details and how to joinNCT06541847 - 1/2. fázisTaking peopleEarly Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
- Where
- Dallas, Washington D.C.
- Életkor
- 18 év and over
- People
- 45
- Run by
- AeRang Kim
See details and how to joinNCT06735820 - No phaseTaking peopleTailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
- Where
- Boston
- Életkor
- 18 év and over
- People
- 50
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07233408 - No phaseTaking peopleFamilial Investigations of Childhood Cancer Predisposition
- Where
- Memphis
- People
- 1500
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT03050268 - 2. fázisTaking peopleSelumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
- Where
- Baltimore, Bethesda, Birmingham, Boston, Chicago, Cincinnati, Dallas, Indianapolis, Los Angeles, Palo Alto, Philadelphia, Rochester, St Louis, Washington D.C.
- Életkor
- 1 év to 8 év
- People
- 200
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06188741 - 1. fázisTaking peopleFeasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
- Where
- Baltimore
- Életkor
- 18 év and over
- People
- 10
- Run by
- Johns Hopkins University
See details and how to joinNCT07102394 - No phaseTaking peopleIdentification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
- Where
- Los Angeles
- Életkor
- 5 év to 17 év
- People
- 15
- Run by
- Nicole Baca
See details and how to joinNCT04763109 - 1. fázisCsak meghívásosAssessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)
- Where
- Boston
- Életkor
- 18 év to 85 év
- People
- 15
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06300502 - 1/2. fázisTaking peopleMirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
- Where
- Baltimore
- Életkor
- 18 év and over
- People
- 24
- Run by
- Johns Hopkins University
See details and how to joinNCT06159166